← Back to Search

Clavulin group without polyps for Chronic Sinus Infection

Phase 4
Waitlist Available
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This is a randomized, double-blind clinical trial on the prophylactic use of antibiotics in postoperative endoscopic sinus vs placebo surgery. Patients with chronic rhinosinusitis with or without polyps who have consented to endoscopic sinus surgery according to Canadian practice guidelines may be included in the study after approval by the Research Ethics Board of the University Hospital Center. Quebec and signature of consent.

Eligible Conditions
  • Chronic Sinus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Modified Lund-Kennedy endoscopic score
Quality of life of patients SNOT-22
Rate of infection
+2 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Clavulin group without polypsActive Control1 Intervention
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery
Group II: Clavulin group with polypsActive Control1 Intervention
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery
Group III: Placebo group with polypsPlacebo Group1 Intervention
Group who will receive placebo after the endoscopic sinus surgery in prophylactic and who have polyps in the surgery
Group IV: Placebo group without polypsPlacebo Group1 Intervention
Group who will receive clavulin after the endoscopic sinus surgery in prophylactic and who haven't polyps in the surgery

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
168 Previous Clinical Trials
107,367 Total Patients Enrolled
~23 spots leftby Jun 2025